NATIONAL HEALTH INVESTORS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $NHI in the last 30 days.
See all $NHI insider activity →Argus lowered its target price for National Health Investors (NHI) to $62, maintaining a HOLD rating. The company has medium industry, management, safety, and financial strength ratings, with low growth and value subratings.
National Health Investors (NHI) will release Q3 2026 earnings on Nov. 9, followed by a conference call on Nov. 10. The REIT focuses on senior housing and medical facilities, with a portfolio spanning various care types. NHI's earnings release and call details are provided for investors.
National Health Investors (NYSE:NHI) invested $107.7M to acquire six senior housing properties, expanding its SHOP segment. The deal increases its partnership with Allegro Living Management and adds 443 units across three states. Analysts project revenues of $516.5M and earnings of $154.7M by 2029, with a potential 25% upside. However, risks include occupancy softness, labor strain, and integration challenges.
Over the past 7 days, AlphAI's AI scored 4 news stories mentioning NHI (NATIONAL HEALTH INVESTORS INC). Coverage has been balanced: 1 bullish, 2 neutral, and 1 bearish.
Recent NHI coverage spans financial news, earnings and mergers & acquisitions.
Potential modest downside as target price cut signals weaker outlook.
The release schedule provides a date for investors to anticipate earnings information, but no new financial data is disclosed.
The acquisition expands NHI's SHOP platform, adding 443 units and increasing operating exposure.
The capital deployment expands NHI's holdings and signals continued growth, supporting a positive outlook.
The acquisition expands NHI's senior‑housing footprint and should be viewed as a positive growth catalyst.
AlphAI scores every news story that mentions NHI with an AI model for sentiment and relevance, and aggregates insider trades from NATIONAL HEALTH INVESTORS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Argus lowered its target price for National Health Investors (NHI) to $62, maintaining a HOLD rating. The company has medium industry, management, safety, and financial strength ratings, with low growth and value subratings.
1 min readNational Health Investors (NHI) will release Q3 2026 earnings on Nov. 9, followed by a conference call on Nov. 10. The REIT focuses on senior housing and medical facilities, with a portfolio spanning various care types. NHI's earnings release and call details are provided for investors.
1 min readNational Health Investors (NYSE:NHI) invested $107.7M to acquire six senior housing properties, expanding its SHOP segment. The deal increases its partnership with Allegro Living Management and adds 443 units across three states. Analysts project revenues of $516.5M and earnings of $154.7M by 2029, with a potential 25% upside. However, risks include occupancy softness, labor strain, and integration challenges.
2 min readLTC Properties (LTC) acquired three senior housing communities for $160M, adding 270 units. National Health Investors (NHI) invested $107.7M in six communities, adding 443 units. Both companies are expanding their senior housing portfolios. Cardinal Senior Living acquired three Ohio communities. Other transactions include sales in Michigan, New York, New Mexico, and South Carolina. JLL arranged $276M in refinancing for a California senior housing portfolio.
2 min readNational Health Investors (NHI) announced a $107.7M investment in six properties with 443 units in Kentucky, Michigan, and Tennessee. The properties will be part of NHI's Senior Housing Operating Portfolio (SHOP) segment and managed by Allegro Living Management. NHI expects an initial NOI yield of 7.0% and 6.6% after capital expenditures. The company also has $164.3M in investment opportunities under signed LOIs and $51.7M in real estate purchase options.
2 min readNHI (NHC) announced a $107.7M investment in SHOP, though details on returns, financing, and impact were not disclosed. The move signals capital deployment into SHOP assets.
1 min readBMO Capital reiterated an Outperform rating and $80.00 price target on National Health Investors (NHI). The company, trading near its 52-week low, focuses on growth through acquisitions and its SHOP portfolio. NHI reported Q2 2026 earnings beating profit expectations but missing revenue forecasts, with a dividend increase and asset sale gains. Truist Securities lowered its price target to $80, maintaining a Buy rating.
2 min readNATIONAL HEALTH INVESTORS INC (NHI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, National Health Investors, Inc. (the “Company”) entered into a Change in Control Severance Agreement (
1 min readNHI reported Q2 2026 earnings with net income per share up 45.6% to $1.15, driven by real estate sales. NAREIT FFO per share remained flat at $1.19, while normalized FFO per share decreased 2.5% due to transition costs. The company completed a $560M portfolio sale, increasing liquidity and reducing leverage. NHI plans to expand its senior housing operating portfolio (SHOP) to 40-50% of its total portfolio within three years, with $127.3M in new investments under signed letters of intent. The qua
3 min readNational Health Investors (NHI) said its SHOP segment rose to 24% of total NOI and continued growing in 2Q26, though same-store SHOP occupancy fell to 85.1% from 89.1% in 4Q25. Same-store RevPOR increased to $3,187. G&A rose to $8.8M. NHI hired a new COO and CFO, and aims to raise SHOP to 40% to 50% of NOI.
6 min read
